BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37779403)

  • 21. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
    Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
    Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.
    Jia Y; Yan Q; Zheng Y; Li L; Zhang B; Chang Z; Wang Z; Tang H; Qin Y; Guan XY
    J Exp Clin Cancer Res; 2022 Sep; 41(1):287. PubMed ID: 36171622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA NEAT1 regulates the growth, migration, and invasion of the human esophageal cancer cells via the miR-377/E2F3 axis.
    Du W; Xu P; Yin H
    Acta Biochim Pol; 2022 Oct; 69(4):731-736. PubMed ID: 36252156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA NEAT1 promotes viability and migration of gastric cancer cell lines through up-regulation of microRNA-17.
    Wang CL; Wang D; Yan BZ; Fu JW; Qin L
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4128-4137. PubMed ID: 30024601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer.
    Li Y; Peng C; Fang C; Huang K
    Cell Biol Int; 2020 Feb; 44(2):446-455. PubMed ID: 31617275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non‑coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA‑324‑5p and upregulating KCTD20 expression.
    Zhang J; Li Y; Liu Y; Xu G; Hei Y; Lu X; Liu W
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.
    Chen DL; Ju HQ; Lu YX; Chen LZ; Zeng ZL; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Xu DZ; Zhou ZW; Pelicano H; Huang P; Xie D; Wang FH; Li YH; Xu RH
    J Exp Clin Cancer Res; 2016 Sep; 35(1):142. PubMed ID: 27620004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of long noncoding RNA
    Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
    Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An updated review of contribution of long noncoding RNA-NEAT1 to the progression of human cancers.
    Farzaneh M; Masoodi T; Ghaedrahmati F; Radoszkiewicz K; Anbiyaiee A; Sheykhi-Sabzehpoush M; Rad NK; Uddin S; Jooybari SPM; Khoshnam SE; Azizidoost S
    Pathol Res Pract; 2023 May; 245():154380. PubMed ID: 37043964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
    Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
    J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances of NEAT1-miRNA interactions in cancer.
    Zhou H; Wang Y; Liu Z; Zhang Z; Xiong L; Wen Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Feb; 54(2):153-162. PubMed ID: 35538025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Yan L; Zhang J; Guo D; Ma J; Shui SF; Han XW
    Int J Oncol; 2019 Jan; 54(1):7-16. PubMed ID: 30387833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
    Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
    Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. lncRNAs as Hallmarks for Individualized Treatment of Gastric Cancer.
    Wu J; Xu S; Li W; Lu Y; Zhou Y; Xie M; Luo Y; Cao Y; He Y; Zeng T; Ling H
    Anticancer Agents Med Chem; 2022; 22(8):1440-1457. PubMed ID: 34229588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Ning L; Li Z; Wei D; Chen H; Yang C
    Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.